ACHE and Parkinson disease: Additionally, the protein–ligand docking and interaction profiling studies could predict the potential inhibitory effect of the DHE-derived IR3G/IR on AChE, MAO-B, and PLK2, which could improve neurodegenerative diseases, including PD.